Evidence map›Paper›PMID 20130594›Full record

ArticleThe Journal of investigative dermatology2010

Soluble adenylyl cyclase defines a nuclear cAMP microdomain in keratinocyte hyperproliferative skin diseases.

Jonathan H Zippin, Paul A Chadwick, Lonny R Levin, Jochen Buck, Cynthia M Magro

Abstract read
In one paragraph

Article in The Journal of investigative dermatology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Cross-Talk Between the Adenylyl Cyclase/cAMP Pathway and CaReviews of physiology, biochemistry and pharmacology · 2021
    Review
  8. Article
  9. Soluble adenylyl cyclase links CaScientific reports · 2019
    Article
  10. Article
  11. Pharmacological modulation of the COPharmacology & therapeutics · 2018
    Review
  12. Article
  13. Article
  14. Review
  15. Soluble adenylyl cyclase in health and disease.Biochimica et biophysica acta · 2014
    Review
  16. Soluble adenylyl cyclase is necessary and sufficient to overcome the block of axonal growth by myelin-associated factors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2014
    Article
  17. Crystal structures of human soluble adenylyl cyclase reveal mechanisms of catalysis and of its activation through bicarbonate.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  18. Review
  19. Pharmacological distinction between soluble and transmembrane adenylyl cyclases.The Journal of pharmacology and experimental therapeutics · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jonathan H ZippinDepartment of Dermatology, NYPH-Weill Cornell Medical Center, New York, New York, USA. jhzippin@nyp.org
Paul A Chadwick
Lonny R Levin
Jochen Buck
Cynthia M Magro
Cornell University · US

Funding

BICARBONATE REGULATED ADENYLYL CYCLASER01GM062328 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI BUCK, JOCHEN, LEVIN, LONNY R · 2001 to 2013
$4.6M
Soluble adenylyl cyclase isoforms essential for male fertilityR01HD059913 · NICHD · WEILL MEDICAL COLL OF CORNELL UNIV · PI BUCK, JOCHEN, LEVIN, LONNY R · 2009 to 2013
$1.7M
Neuronal growth factor signaling via cAMPR01NS055255 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEVIN, LONNY R · 2007 to 2010
$1.5M
NICHD NIH HHS HD059913NICHD NIH HHS R01 HD059913NIGMS NIH HHS GM62328NIGMS NIH HHS R01 GM062328NINDS NIH HHS NS55255NINDS NIH HHS R01 NS055255
6 · The paper itself

Abstract

Cyclic adenosine monophosphate (cAMP) is a nearly ubiquitous signaling molecule important for numerous signaling pathways in human skin. We studied a novel class of mammalian adenylyl cyclase, the soluble adenylyl cyclase (sAC). We examined sAC localization in normal human skin and found it to be present in keratinocytes, melanocytes, mononuclear cells, eccrine ducts, and nerves. In normal skin, sAC keratinocyte staining was evenly distributed throughout the cell. However, in certain hyperproliferative disorders of the skin, including psoriasis, verruca vulgaris, and SCCIS on sun-damaged skin, sAC keratinocyte staining was predominantly nuclear. In contrast, in other hyperproliferative disorders, such as basal cell carcinoma, sAC staining was similar to normal human skin. Using a model of epithelial differentiation, we established that sAC migrates into the nucleus when differentiated cells are induced to reenter the cell cycle. Previous work had determined that nuclear sAC activates the cAMP-response-element-binding (CREB) transcription factor, and we found that in psoriasis lesions, nuclear sAC occurs concomitantly with activation of CREB. Hence, sAC may play a role in the pathogenesis of certain hyperproliferative skin disorders via modulation of gene expression.

Indexed as

Skin DiseasesAdenylyl CyclasesAnimalsCaco-2 CellsCell DifferentiationCell NucleusCyclic AMPDogsEpidermisHumansKeratinocytesKeratosisKidneyMembrane MicrodomainsMolluscum ContagiosumPsoriasisAdenylyl CyclasesCyclic AMP

Identifiers

PMID20130594
PMCPMC3082439
OpenAlexW2069624412

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.